Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates diabetic nephropathy via suppressing SLC7A11-mediated ferroptosis

International Immunopharmacology 2026

View at publisher
Authors: Lu Yu, Zihan Zhai, Yulin Wang, Liuwei Wang, Qiuhong Li, Y H Guo, Yan Liang, Lin Tang
DOI: 10.1016/j.intimp.2026.116448
Cited by: 1
References: 33

Fields of Study & Subjects

Ferroptosis and cancer prognosis Hormonal Regulation and Hypertension Cholesterol and Lipid Metabolism

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
175
Pages
116448–116448
Publication date
3 March 2026
Language
EN